HOLLY SPRINGS, N.C. -- Genentech, a leading biotechnology company based in San Francisco, is set to build a $700 million manufacturing plant in Wake County, creating over 400 new jobs, Governor Josh ...

Genentech, a biotechnology company based in South San Francisco, could add 400 jobs in the Wake County town of Holly Springs after agreeing to an incentives deal with North Carolina. Why it matters: ...

A new biotechnology plant is set to boost North Carolina's economy by more than $3 billion. Medical manufacturing company ...

Another biotechnology company has set its sights on Holly Springs. California-based Genentech plans to create up 420 jobs in Holly Springs — a deal expected to bring an investment of up to $700 ...

North Carolina state leaders announced a major deal to invest $700 million in a manufacturing plant in Wake County, bringing hundreds of new jobs to the Triangle area.

As the administration pushes for a return to US manufacturing, outsourcing agreements with domestic manufacturers are ...

The biotech giant's new facility is part of a larger U.S. investment strategy, though it may roll back its buildout if the ...

The committee on Monday awarded a grant to Genentech, a Roche subsidiary, to open a 420-worker, drug-manufacturing plant in the fast-growing part of southwestern Wake County. Roche pledged to create ...

Genentech has announced plans to invest more than $700 million in a new 700,000 square foot drug manufacturing facility.

Genentech, a member of the Roche Group, will create 400 jobs with a new biotechnology facility in Holly Springs, Wake County, North Carolina.

San Francisco-based Genentech plans to create up to 420 high-paying jobs in Holly Springs — a project expected to bring an investment of up to $700 million to the southern Wake County town ...